Could new hormone creams protect menopausal Women's hearts?
NCT ID NCT07394049
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This large registry study will follow over 2,700 postmenopausal women aged 45-75 who use newer forms of hormone replacement therapy (creams, gels, sprays). The goal is to see if these modern delivery methods lower the risk of heart attacks, strokes, and other cardiovascular events. Researchers will track health outcomes over time to understand how these hormones affect heart health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hormone replacement therapy (creams, gels, sprays)
What this could lead to
If successful, this study could clarify whether newer HRT delivery methods lower heart disease risk in menopausal women.
What could go wrong
This is an observational registry, not a controlled trial, so it can show links but not prove cause and effect. Results may take years and could be inconclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic for Cardiology, Angiology and Intensive Care at Charité Mitte Berlin
Berlin, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Duesseldorf
Düsseldorf, 40225, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••